Lupin and Sandoz join hands to commercialise biosimilar drug

Mumbai-based drug-maker firm, Lupin, has partnered with Switzerland-based Sandoz Group AG to commercialise the biosimilar drug, ranibizumab, across the EU, Hong Kong, Vietnam, Australia, Norway, Switzerland, and Canada